Core Viewpoint - The technology sector offers high-growth stocks but is cyclical and may underperform during economic downturns, making diversification into more defensive industries like healthcare essential for investors [1]. Group 1: Healthcare Industry Overview - The healthcare sector, particularly pharmaceutical companies like AbbVie and Johnson & Johnson, is recommended for diversification from tech-heavy portfolios [2]. - AbbVie and Johnson & Johnson develop and market drugs across various therapeutic areas, addressing serious health conditions that maintain stable demand even during economic downturns [4]. Group 2: Company Performance in Recessions - AbbVie and Johnson & Johnson tend to perform well during recessions due to the essential nature of their products, despite facing challenges such as patent cliffs and competition [5]. - Both companies have shown resilience by developing new products to offset patent expirations, with AbbVie successfully navigating the loss of exclusivity for Humira and Johnson & Johnson managing well despite losing patent protection for Stelara [6]. Group 3: Financial Stability and Credit Ratings - Johnson & Johnson holds a higher credit rating than the U.S. government, indicating strong financial stability, which is crucial during economic downturns [7]. Group 4: Dividend Performance - AbbVie has increased its dividend payouts for 54 consecutive years, while Johnson & Johnson has done so for 63 years, qualifying both as Dividend Kings [8][9].
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio